戻る Agenda
Plenary Session : Navigating Regulatory Transformation : Insights and Innovations in Asian Healthcare
Session Chair(s)
Finny Liu, MSC, RPH
APAC Regional Regulatory Policy Lead, Roche, Singapore
Helene Sou, MSC, RAC
Global Regulatory Policy and Innovation, Takeda Pharmaceutical Company Limited., Singapore
Speaker(s)
Finny Liu, MSC, RPH
APAC Regional Regulatory Policy Lead, Roche, Singapore
Thu Hien Ngo
Officer, New Drug Registration, Drug Administration of Vietnam (DAV), Vietnam
Ambrose WONG
Principle Medical & Health Officer (Medical Device), Department of Health, Hong Kong
Pramote Akarapanon
Head of New Drug and Investigational Drug, , Thai Food and Drug Administration, Thailand
Neil McAuslane, PHD, MSC
Scientific Director, Centre for Innovation in Regulatory Science (CIRS), United Kingdom
John CW Lim, MD, MSC
Executive Director, Centre of Regulatory Excellence, Duke-NUS Medical School, Si, Singapore
Carlos Garner, PHD, MSC
Senior Vice-President Global Regulatory Affairs and Head, Lilly Regenerative Med, Eli Lilly and Company, United States